Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Ďuraš · SciRah

Researcher profile · Semantic Scholar

J. Ďuraš

Share profile

J. Ďuraš — researcher profile on SciRah

h-index: 11
Works: 86
Citations: 442

Most-cited papers

PD‐1/PD‐L1 inhibitors in haematological malignancies: update 2017
T. Jelínek, J. Mihályová, M. Kaščák, J. Ďuraš +1 more
2017Immunology119 citations Open access
Semantic Scholar
Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14)
T. Jelínek, J. Mihályová, M. Kaščák, J. Ďuraš +16 more
2018American journal of hematology/oncology41 citations
Semantic Scholar
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients
A. Janíková, R. Chloupková, V. Campr, P. Klener +11 more
2019Annals of Hematology35 citations
Semantic Scholar
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world
Prokop Vodička, K. Benešová, A. Janíková, V. Prochazka +9 more
2021European Journal of Haematology32 citations
Semantic Scholar
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
A. Janíková, Z. Bortlíček, V. Campr, N. Kopálová +10 more
2015Leukemia and Lymphoma31 citations
Semantic Scholar
Strategically Developed Strong Red‐Emitting Oxyfluoride Nanophosphors for Next‐Generation Lighting Applications
Malini Abraham, K. K. Thejas, A. Kunti, N. Amador-Méndez +6 more
2024Advanced Optical Materials19 citations
Semantic Scholar
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma
T. Jelínek, Lucie Adamusova, T. Popková, Ivana Tvrdá +10 more
2018Bone Marrow Transplantation17 citations
Semantic Scholar
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database
A. Janíková, Z. Bortlíček, V. Campr, N. Kopálová +11 more
2018Annals of Hematology16 citations
Semantic Scholar
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
H. Móciková, R. Pytlík, K. Benešová, A. Janíková +8 more
2021Frontiers in Oncology13 citations Open access
Semantic Scholar
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort
T. Jelínek, T. Popková, J. Ďuraš, J. Mihályová +7 more
2020Hematological Oncology13 citations
Semantic Scholar
Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia
Z. Král, J. Michalka, H. Móciková, J. Marková +13 more
2019Journal of Cancer13 citations Open access
Semantic Scholar
Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
Lori A. Leslie, Che-Ah Y. Chan, F. Morschhauser, Justin M. Darrah +11 more
2024Blood10 citations
Semantic Scholar
Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial
J. Vermaat, Joshua D. Brody, J. Ďuraš, Y. Karimi +9 more
2023Blood8 citations Open access
Semantic Scholar
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
A. Janíková, Z. Bortlíček, V. Campr, N. Kopálová +11 more
2016Leukemia and Lymphoma8 citations
Semantic Scholar
IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY?
M. Trněný, K. Polgárová, A. Janíková, D. Belada +9 more
2019Hematological Oncology6 citations
Semantic Scholar
Epcoritamab + R-mini-CHOP results in 2-year remissions and high MRD negativity rates in elderly patients with newly diagnosed DLBCL: Results from the EPCORE NHL-2 trial
Che-Ah Y. Chan, J. Ďuraš, D. Belada, Justin M. Darrah +17 more
2025Blood4 citations
Semantic Scholar
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data
H. Móciková, A. Janíková, A. Sýkorová, V. Prochazka +10 more
2024Annals of Hematology4 citations Open access
Semantic Scholar
Bayesian Network Modelling As a New Tool in Predicting of the Early Progression of Disease in Follicular Lymphoma Patients
V. Prochazka, Štěpánka Matuštíková, T. Fürst, D. Belada +11 more
20204 citations Open access
Semantic Scholar
The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI)
M. Trněný, P. Klener, D. Belada, H. Móciková +15 more
20144 citations Open access
Semantic Scholar
[Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
Zdeněk Adam, Petr Szturz, J. Ďuraš, L. Pour +7 more
2012Klinicka onkologie4 citations
Semantic Scholar
Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
K. Dědečková, M. Andrlík, H. Móciková, L. Kaliská +19 more
2025Radiotherapy and Oncology3 citations Open access
Semantic Scholar
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
A. Janíková, J. Michalka, R. Chloupková, N. Kopálová +11 more
2022Annals of Hematology3 citations
Semantic Scholar
Osteolytic bone lesions, hypercalcemia and paraprotein, but not a myeloma: case report and review of literature.
K. Hradská, T. Jelínek, J. Ďuraš, J. Mihályová +6 more
2020Vnitrni lekarstvi3 citations Open access
Semantic Scholar
The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group.
D. Belada, V. Prochazka, A. Janíková, V. Campr +9 more
2018Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations
Semantic Scholar
Long‐Term Real‐World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results
Prokop Vodička, A. Janíková, D. Belada, V. Hanáčková +11 more
2025Hematological Oncology2 citations Open access
Semantic Scholar
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration
A. Sýkorová, František Folber, K. Polgárová, H. Móciková +21 more
2024Cancer Medicine2 citations Open access
Semantic Scholar
P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
J. Michalka, J. Marková, Ľ. Gahérová, M. Maco +14 more
2022HemaSphere2 citations Open access
Semantic Scholar
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
A. Sýkorová, V. Prochazka, H. Móciková, A. Janíková +9 more
2022Neoplasma (Bratislava)2 citations Open access
Semantic Scholar
Early Follicular Lymphoma Progression in Patients Treated with Frontline Immunochemotherapy with/without Rituximab Maintenance: Clinically Meaningful Even in Chemosensitive Individuals
V. Prochazka, D. Belada, A. Janíková, K. Benešová +11 more
2019Blood2 citations
Semantic Scholar
PREDICTIVE VALUE OF PRIMA‐PROGNOSTIC INDEX (PRIMA‐PI) IN FIRST RELAPSE OF FOLLICULAR LYMPHOMA
J. Ďuraš, V. Prochazka, D. Belada, A. Janíková +4 more
2019Hematological Oncology2 citations
Semantic Scholar
Population-Based Analysis of Elderly Patients (>70 YEARS) with Peripheral T-CELL Lymphoma: A Results from Czech Lymphoma Study Group (CLSG) Registry
A. Janíková, R. Pytlík, P. Klener, Z. Bortlíček +11 more
20162 citations
Semantic Scholar
Bulky disease and/or very high LDH define a high-risk LBCL subgroup within IPI 1–2, but only in younger patients
Prokop Vodička, D. Šálek, K. Benešová, D. Belada +18 more
2025Blood1 citations
Semantic Scholar
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
Prokop Vodička, Yu-Cai Wang, K. Benešová, Patrick M. Reagan +43 more
2025Blood1 citations
Semantic Scholar
FLIPI24 as a prognostic model in marginal zone lymphoma: Results from an international multi-cohort analysis
Prokop Vodička, Matthew J. Maurer, Michal Masar, Yu-Cai Wang +36 more
2025Blood1 citations
Semantic Scholar
REAL WORLD OUTCOMES OF THE FIRST‐LINE TREATMENT OF LOCALIZED EXTRANODAL MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXA OR ORBIT
J. Ďuraš, P. Vodička, A. Janíková, D. Belada +17 more
2025Hematological Oncology1 citations
Semantic Scholar
Validation of novel prognostic models in symptomatic Waldenström's macroglobulinemia based on real-world data
M. Kaščák, Prokop Vodička, K. Menšíková, Štork Martin +40 more
2025Blood1 citations
Semantic Scholar
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Ondrej Šušol, Barbora Šušolová, O. Klempíř, Milan Navrátil +20 more
2024Cancer Medicine1 citations
Semantic Scholar
Results from the Epcore NHL-2 Trial Arm 8: Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP
J. Vermaat, J. Brody, J. Ďuraš, Y. Karimi +9 more
2024Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Survival of Patients with Primary Mediastinal B-Cell Lymphoma Treated By Immunochemotherapy with or without Radiotherapy
K. Polgárová, A. Janíková, D. Belada, V. Prochazka +8 more
2022Blood1 citations Open access
Semantic Scholar
How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice?
Prokop Vodička, K. Benešová, A. Janíková, D. Belada +11 more
2022Blood1 citations Open access
Semantic Scholar
Is It Better to Start Treatment with ABVD and Continue with PET2-Adapted Approach or Should We Use 2 Cycles of Beacopp Escalated and 2 Cycles of ABVD and Irradiation in Early Unfavorable Hodgkin Lymphoma?
H. Móciková, J. Marková, Ľ. Gahérová, M. Maco +8 more
2021Blood1 citations
Semantic Scholar
CHARACTERIZATION OF DUVELISIB IN PATIENTS WITH REFRACTORY MARGINAL ZONE LYMPHOMA: DATA FROM THE PHASE 2 DYNAMO TRIAL
E. Jacobsen, J. Ďuraš, K. Ardeshna, M. Cherry +11 more
2019Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment
T. Popková, K. Hradská, J. Mihályová, Michaela Škorupová +9 more
2019Blood1 citations Open access
Semantic Scholar
An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database
Cosimo Lobello, A. Janíková, L. Křen, M. Hermanová +10 more
20171 citations Open access
Semantic Scholar
Beyond rituximab maintenance. relapsing follicular lymphoma during or after end of rituximab maintenance: analysis of Czech Lymphoma Study Group (CLSG) database
A. Janíková, V. Campr, Natasa Kopalova, K. Benešová +9 more
20171 citations Open access
Semantic Scholar
Ibrutinib v hematoonkologii
J. Mihályová, J. Ďuraš, J. Zuchnická, M. Kaščák +1 more
20161 citations Open access
Semantic Scholar
Low Hodgkin/Reed-Sternberg Cell Density Assessed with Automated Image Analysis Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients
V. Prochazka, T. Dýšková, Z. Prouzová, T. Papajík +7 more
20151 citations
Semantic Scholar
Comparison of the HemoScreen Point-Of-Care Haematology Analyser With Sysmex XN, Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts.
K. Hradská, M. Pulcer, Michaela Škorupová, T. Popková +10 more
2026International Journal of Laboratory Hematology0 citations Open access
Semantic Scholar
Survival Improvement of DLBCL Patients Treated with Third Line and Beyond in the Recent Era in the Czech Republic.
Prokop Vodička, A. Janíková, K. Polgárová, J. Ďuraš +17 more
2026Blood Advances0 citations Open access
Semantic Scholar
The Efficacy and Toxicity of CNS Prophylaxis in Diffuse Large B‐Cell Lymphoma (CLSG‐CNS‐01): A Randomized, Multicenter, Prospective Phase 3 Trial
H. Móciková, Ľ. Gahérová, T. Jancarkova, A. Suri +9 more
2026Hematological Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Belada×35
Invite
D. Belada — researcher profile on SciRah
H. Móciková×33
Invite
H. Móciková — researcher profile on SciRah
V. Prochazka×31
Invite
V. Prochazka — researcher profile on SciRah
A. Janíková×28
Invite
A. Janíková — researcher profile on SciRah

×21

Invite

V. Campr — researcher profile on SciRah

K. Benešová×20

Invite

K. Benešová — researcher profile on SciRah

A. Sýkorová×20

Invite

A. Sýkorová — researcher profile on SciRah

M. Trněný×16

Invite

M. Trněný — researcher profile on SciRah

Invite

R. Pytlík — researcher profile on SciRah

P. Blahovcová×14

Invite

P. Blahovcová — researcher profile on SciRah

Invite

J. Pirnos — researcher profile on SciRah

M. Kaščák×10

Invite

M. Kaščák — researcher profile on SciRah